Accessibility Menu
 
Codexis logo

Codexis

(NASDAQ) CDXS

Current Price$1.59
Market Cap$145.39M
Since IPO (2010)-88%
5 Year-93%
1 Year-37%
1 Month+37%

Codexis Financials at a Glance

Market Cap

$145.39M

Revenue (TTM)

$70.39M

Net Income (TTM)

$43.97M

EPS (TTM)

$-0.52

P/E Ratio

-3.09

Dividend

$0.00

Beta (Volatility)

1.89 (High)

Price

$1.59

Volume

52,267

Open

$1.64

Previous Close

$1.59

Daily Range

$1.55 - $1.66

52-Week Range

$0.96 - $3.87

CDXS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Codexis

Industry

Life Sciences Tools and Services

Employees

146

CEO

Alison Moore, PhD

Headquarters

Redwood City, CA 94063, US

CDXS Financials

Key Financial Metrics (TTM)

Gross Margin

79%

Operating Margin

-54%

Net Income Margin

-62%

Return on Equity

-75%

Return on Capital

-31%

Return on Assets

-30%

Earnings Yield

-32.36%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$145.39M

Shares Outstanding

90.87M

Volume

52.27K

Short Interest

0.00%

Avg. Volume

2.21M

Financials (TTM)

Gross Profit

$55.95M

Operating Income

$38.33M

EBITDA

$30.04M

Operating Cash Flow

$19.38M

Capital Expenditure

$4.47M

Free Cash Flow

$23.85M

Cash & ST Invst.

$78.21M

Total Debt

$73.21M

Codexis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$38.91M

+81.3%

Gross Profit

$31.77M

+78.5%

Gross Margin

81.65%

N/A

Market Cap

$145.39M

N/A

Market Cap/Employee

$773.36K

N/A

Employees

188

N/A

Net Income

$9.60M

+192.5%

EBITDA

$16.95M

+304.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$5.00M

-63.1%

Accounts Receivable

$10.73M

-43.2%

Inventory

$1.82M

+1.0%

Long Term Debt

$70.26M

+23.1%

Short Term Debt

$2.94M

+4.1%

Return on Assets

-29.75%

N/A

Return on Invested Capital

-31.30%

N/A

Free Cash Flow

$19.57M

+207.3%

Operating Cash Flow

$20.09M

+222.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SGMOSangamo Therapeutics, Inc.
$0.33-2.73%
IMDXInsight Molecular Diagnostics Inc.
$4.26+8.67%
IPHAInnate Pharma S.A.
$1.17-7.87%
IVVDInvivyd, Inc.
$1.38-4.83%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%
QQQInvesco QQQ Trust
$582.06-0.02%

Questions About CDXS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.